Early Detection of Cervical Cancer and Monitoring in Estonia 2012-2019

Kerli Mooses
Cervical cancer is one of the most common cancer in women worldwide which is preventable with an early detection and vaccination. The aim of the study was to evaluate the usage of diagnostic tests that were carried out for early detection of cervical cancer in Estonia and their adherence to treatment guidelines.
In 2012–2019 there were 85.1% of women aged 21–65 years who had received at least one PAP or HPV test. At the same time, there were 13.7% of women whose time between two PAP tests was more than 3.5 years. As expected, there was a significant decrease in the number of PAP tests among 16–44 and 55–65 year-old women during the 3rd version of treatment guidelines (2016–2019) and increase in the number of HPV tests in women over 30 compared with the 2nd version of guidelines (2012– 2014) (p < 0.05). As for women aged 21–24 and 25–29 tested for HPV, there were women without previous PAP test present (5.1% and 7.7% respectively) and women with PAP test result which did not require subsequent HPV test according to the treatment guidelines (46.4% ja 47.3%, respectively). Within one year after receiving HSIL diagnosis colposcopy was performed to 74.4% of women.
Despite the occurrence of some over testing, there is a good adherence to cervical cancer prevention guidelines in Estonia. However, more efforts should be made to get never or irregularly tested women to participate regularly in cervical cancer testing.
Graduation Thesis language
Graduation Thesis type
Master - Conversion Master in IT
Raivo Kolde, Marek Oja, Sirli Tamm
Defence year